NXS 0.00% 20.0¢ next science limited

This isn't a David and Goliath battle it's David and...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 142 Posts.
    lightbulb Created with Sketch. 33
    This isn't a David and Goliath battle it's David and Godzilla...or maybe bigger. ZB's speciality is orthopeadics, right in NXS's currently desired sweetspot. Hate to have to say it, but they're someone you would want to have a good relationship with because they're one of the major players, I think third by revenue in this space 2 or 3 years ago. The largest by revenue was Stryker, and then Depuy Synthes (according to the article below). Interesting article here about the industry and it's ongoing purchasing of much needed tecchnology. DYOR

    https://www.odtmag.com/issues/2019-08-14/view_features/the-2019-top-10-global-orthopedic-device-firms-955005/
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.